Barnes, N. M. (2005). "5-HT3 receptor antagonists ameliorate fatigue: so much potential, so little knowledge!" Gut 54(8): 1056-1057.

	There is growing evidence that 5-HT3 receptor blockade will benefit patients with fatigue. Further research is needed to determine the mechanism underlying this widespread clinically important symptom and therapies may be derived from targeting the 5-HT system.

